A Phase 1b Study to Evaluate the PK of CSL300 (Clazakizumab) in Chinese Subjects With End Stage Kidney Disease (ESKD)

Abroad (travel likely)RecruitingPHASE1

Conditions

End Stage Kidney Disease (ESKD)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Peking University People's Hospital, Beijing, China

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

End Stage Kidney Disease

IsraelRecruitingPHASE2, PHASE3

Decatur, United States · Huntsville, United States

Moda-flx Hemodialysis System™ Under Professional Care Settings by Trained Individuals and At Home by Participants

End Stage Kidney Disease

Abroad (travel likely)Recruiting

San Dimas, United States · New Hyde Park, United States

DIALysis With EXpanded Solute Removal

Chronic Kidney Disease Requiring Hemodialysis · End-Stage Kidney Disease (ESKD) · Chronic Kidney Disease Requiring Chronic Dialysis

Abroad (travel likely)Recruiting

London, Canada

Duke APOL1 Research Biorepository

End Stage Kidney Disease

Abroad (travel likely)Recruiting

Durham, United States